Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Cantor Fitzgerald
US Army

Generated: March 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091575

« Back to Dashboard

NDA 091575 describes TROSPIUM CHLORIDE, which is a drug marketed by Actavis Labs Fl Inc, Paddock Llc, Upsher-smith Labs, Apotex, Glenmark Generics, Heritage Pharms Inc, and Invagen Pharms, and is included in eight NDAs. It is available from eleven suppliers. Additional details are available on the TROSPIUM CHLORIDE profile page.

The generic ingredient in TROSPIUM CHLORIDE is trospium chloride. There are sixteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.
Summary for 091575
Applicant:Glenmark Generics
Ingredient:trospium chloride
Therapeutic Class:Genitourinary Agents
Pharmacology for NDA: 091575
Suppliers and Packaging for NDA: 091575
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091575 ANDA Glenmark Pharmaceuticals Inc., USA 68462-461 N 68462-461-05
TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091575 ANDA Glenmark Pharmaceuticals Inc., USA 68462-461 N 68462-461-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Aug 13, 2010TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
US Army
Chinese Patent Office
Boehringer Ingelheim
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.